Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Palmer

Showing results (71-80 of 161) with videos related to

Pageof 17
Sort By:
Journal of Personality Disorders|October 13, 2006
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trialKate Davidson, John Norrie, Peter Tyrer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Health Technology Assessment (Winchester, England)|March 1, 2017
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisalRobert Hettle, Mark Corbett, Sebastian Hinde, et al.
International Journal of Antimicrobial Agents|December 19, 2008
The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practiceM Fasihul Alam, David Cohen, Christopher Butler, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Pharmacoeconomics|August 17, 2018
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalRos Wade, Alessandro Grosso, Emily South, et al.
Health Technology Assessment (Winchester, England)|November 28, 2015
Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysisRos Wade, Eleftherios Sideris, Fiona Paton, et al.
Pharmacoeconomics|April 27, 2013
Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisalRita Faria, Eldon Spackman, Jane Burch, et al.
Endocrinology|February 3, 2007
Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processingRichard M Thomas, Cheryl A Nechamen, Joseph E Mazurkiewicz, et al.
Plos One|January 26, 2013
A platform for the remote conduct of gene-environment interaction studiesJohn Gallacher, Rory Collins, Paul Elliott, et al.
Pageof 17

Showing results (71-80 of 161) with videos related to

Sort By:
Pageof 17
Journal of Personality Disorders|October 13, 2006
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trialKate Davidson, John Norrie, Peter Tyrer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Health Technology Assessment (Winchester, England)|March 1, 2017
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisalRobert Hettle, Mark Corbett, Sebastian Hinde, et al.
International Journal of Antimicrobial Agents|December 19, 2008
The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practiceM Fasihul Alam, David Cohen, Christopher Butler, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Pharmacoeconomics|August 17, 2018
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalRos Wade, Alessandro Grosso, Emily South, et al.
Health Technology Assessment (Winchester, England)|November 28, 2015
Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysisRos Wade, Eleftherios Sideris, Fiona Paton, et al.
Pharmacoeconomics|April 27, 2013
Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisalRita Faria, Eldon Spackman, Jane Burch, et al.
Endocrinology|February 3, 2007
Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processingRichard M Thomas, Cheryl A Nechamen, Joseph E Mazurkiewicz, et al.
Plos One|January 26, 2013
A platform for the remote conduct of gene-environment interaction studiesJohn Gallacher, Rory Collins, Paul Elliott, et al.
Pageof 17